Purchase of Russian cancer drugs
March 19, 2017, 12:00 pm
The Commission to Investigate Allegations of Bribery or Corruption (CIABOC) has recorded a statement from Dr. Rukshan Bellana, President of the Government Medical Officers’ Forum (GMOF) in respect of alleged irregular registration of two cancer drugs produced in the Russian Federation.
Dr. Bellana complained to CIABOC in December last year in the wake of yahapalana government deciding to import Trustuzumab and Bivasuzumab from Russia to treat cancer patients. Dr. Bellana also alleged that a staggering Rs. 700 mn had been so far spent on those drugs.
Dr. Bellana in his complaint and statement alleged that the government hadn’t even consulted cancer specialists before the decision was made. The College of Oncologists hadn’t been consulted and though some senior specialists opposed the move the government went ahead with the decision, Dr. Bellana had said.
The GMOF president alleged that the decision makers had been in such a hurry that they simply ignored procedures though even Russia had started using Trustuzumab only in January last year. There hadn’t been sufficient clinical trials, he said.
Dr. Bellana pointed out that three reputed Indian manufacturers had been denied the opportunity to register the same product, Trustuzumab. (SF)